New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in ...

Eli Lilly is looking to approach regulators for approval of its once-weekly insulin for type 2 diabetes (T2D) after it proved ...

Novo Nordisk has stated that its flagship insulin brand Mixtard will continue to be available in India in vial form, even as the company phases out other delivery formats such as Penfill ...

India News: In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, Human Mixtard, among other ol.

USA TODAY set out to find out what patients can do. Why are advocates worried about insulin shortages? Advocates for diabetes patients who need insulin to survive worry the nation's supply has become ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply has become unreliable. Certain brands of insulin have been periodically in shortage since late 2023.

Insulin prices have risen 24% since 2017, with spending in the last decade tripling to $22.3 billion in 2022, according to the American Diabetes Association.

She had been using the insulin brand Novolog for years before her new insurance confirmed it only covers Humalog. If she wants to switch back Novolog, she has to get special authorization — and ...

Insulin lowers blood sugar levels much more rapidly after exercise. Andrew, now 18 and a freshman at Florida State University, has again adjusted his insulin intake based on his classes and exercise.